Wednesday, November 25, 2009
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM ... - Gerson Lehrman Group
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM ...Gerson Lehrman Group... last Friday top-line data from the BLOSSOM trial, the final phase 3 study for lorcaserin, an obesity drug targeting the serotonin 5HT2c receptor. ...and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment